What is the free testosterone level considered low in a 45-year-old male with hypogonadism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Free Testosterone Threshold for Hypogonadism in Males

In a 45-year-old male, free testosterone below 220 pmol/L (approximately 6.3 ng/dL) measured by equilibrium dialysis, combined with specific hypogonadal symptoms, establishes the diagnosis of hypogonadism. 1

Diagnostic Thresholds

Total Testosterone Criteria

  • Two separate morning (8-10 AM) fasting measurements below 300 ng/dL (10.4 nmol/L) are required to establish biochemical hypogonadism 1, 2
  • Total testosterone above 350 ng/dL typically does not require replacement therapy 2
  • Levels between 231-346 ng/dL represent a gray zone requiring free testosterone measurement and symptom assessment 2

Free Testosterone Criteria

  • Free testosterone below 220 pmol/L (6.3 ng/dL) by equilibrium dialysis is the gold standard threshold for diagnosing hypogonadism 1
  • Free testosterone measurement is essential when total testosterone is borderline (231-346 ng/dL), particularly in men with obesity or diabetes where low sex hormone-binding globulin (SHBG) may artificially lower total testosterone 1, 3
  • The European Male Ageing Study established that free testosterone below 220 pmol/L combined with three sexual symptoms (erectile dysfunction, reduced frequency of sexual thoughts, and reduced morning erections) defines true hypogonadism 4

Critical Diagnostic Requirements

Symptom Confirmation Required

  • Biochemical evidence alone is insufficient—specific hypogonadal symptoms must be present 1, 5
  • Primary symptoms warranting treatment include diminished libido, erectile dysfunction, and reduced spontaneous erections 1, 3
  • Secondary symptoms include decreased sense of vitality, reduced muscle mass, and increased visceral adiposity 1, 5

Measurement Methodology

  • Free testosterone must be measured by equilibrium dialysis, not calculated methods or free androgen index 1, 3
  • Calculated free testosterone methods show significant variability with mean biases ranging from 5.8% to 56.0% 6
  • Free androgen index correlates poorly with true free testosterone (r²=0.21-0.46) and over-estimates free testosterone at low SHBG concentrations 6

Common Diagnostic Pitfalls

Avoid Single Measurements

  • Testosterone exhibits significant diurnal variation—single measurements are insufficient for diagnosis 3
  • Both total and free testosterone must be confirmed low on at least two separate morning assessments 1, 3

Distinguish Primary from Secondary Hypogonadism

  • After confirming low testosterone, measure LH and FSH to determine the type of hypogonadism 1, 3
  • This distinction has critical treatment implications, particularly for fertility preservation 1
  • Men with secondary hypogonadism seeking fertility require gonadotropin therapy (hCG plus FSH), not testosterone replacement 1

Evaluate for Reversible Causes

  • Obesity-associated secondary hypogonadism may improve with weight loss through low-calorie diets and exercise before initiating testosterone therapy 1
  • Chronic diseases (type 2 diabetes, metabolic syndrome, COPD, cardiovascular disease) are associated with high prevalence of hypogonadism 5, 4
  • Medications including opiates and corticosteroids commonly cause hypogonadism 5

Treatment Threshold Algorithm

For a 45-year-old male:

  1. If free testosterone ≥220 pmol/L: No testosterone replacement indicated regardless of symptoms 1, 4
  2. If free testosterone <220 pmol/L with confirmed hypogonadal symptoms on two separate morning measurements: Testosterone replacement therapy is indicated 1, 3
  3. Target mid-normal testosterone levels (500-600 ng/dL) during treatment 1, 2

Expected Treatment Outcomes

  • Small but significant improvements in sexual function and libido (standardized mean difference 0.35) 1, 7
  • Testosterone therapy produces little to no effect on physical functioning, energy, vitality, or cognition 1
  • Improvements in sexual activity are sustained at 24 months of treatment 7

References

Guideline

Testosterone Injection Treatment for Male Hypogonadism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Target Testosterone Level in Testosterone Replacement Therapy (TRT)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Approach and Management of Hypogonadism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.